baber/WOPTO huggingface dataset:
Patent AU-2020338819-A1 (AU)
Title: Underwater hook with actuation button and release button
Inventor: MÜHLBERGER LUKAS
IPC: B66C1/36
Filed: 2020-08-28
Abstract: The invention relates to an underwater hook (1) with a jaw latch (4) which is releasably secured in a position which closes the hook jaw (2) when the underwater hook is in a secured state (6). The underwater hook additionally has an actuation button (24) which is connected to the jaw latch so as to transmit a movement in order to open the jaw latch and is in a closed position (26, 63) when the underwater hook is secured. The underwater hook (1) is also provided with a release button (25) which blocks a movement of the actuation button out of the closed position when the underwater hook is secured. The aim of the invention is to allow the release button (25) to be actuated without a great degree of effort even in the event of high forces acting on the jaw latch (4). According to the invention, this is achieved in that the release button (25) is in engagement with the actuation button (24) when the underwater hook (1) is secured (6).
Patent AU-2020346195-A1 (AU)
Title: Method, apparatus, and system for controlling string inverter, and storage medium
Inventor: YU XINYU
IPC: H02M7/12
Filed: 2020-08-26
Abstract: The present application relates to the technical field of photovoltaics, and disclosed are a method, apparatus and system for controlling a string inverter and a storage medium. The method comprises: during the process of performing IV curve scanning for one or more first DC/DC boost circuits, controlling the change in the output voltage of one or more second DC/DC boost circuits that do not need to perform IV curve scanning, wherein the change trend appears to have a non-strictly monotonic increasing relationship with the change trend of the input voltage of the one or more first DC/DC boost circuits that perform IV curve scanning. In the foregoing manner, for DC/DC boost circuits that perform IV curve scanning, the voltage difference across two ends of the DC/DC boost circuits will not always be in a relatively high state, so that the ripple current on an input inductor in the DC/DC boost circuits may be reduced, that is too say, the DC/DC boost circuits may be prevented from triggering overcurrent protection due to excessive ripple current on the input inductor.
Patent AU-2020359673-A1 (AU)
Title: Acoustic nebuliser for delivery of active agents
Inventor: YEO LESLIE
IPC: A61M37/00
Filed: 2020-10-05
Abstract: A nebuliser for nebulising liquid droplets, including: a housing; at least one piezoelectric substrate (2) accommodated within the housing and having a transducer surface (2a) upon which is located at least one electroacoustic transducer (48) for generating acoustic wave energy within the at least one piezoelectric substrate (2), and an opposing non-transducer surface (2b); a liquid supply system for supplying a liquid to at least one of the transducer and non-transducer surfaces, the liquid supply system including a reservoir (3) for accommodating the liquid, and at least one relatively rigid supply conduit in contact with the at least one piezoelectric substrate (2) for supplying the liquid from the reservoir (3) to the at least one piezoelectric substrate (2); and a sensor for detecting a volume of liquid on the at least one piezoelectric substrate (2).
Patent AU-2020365197-A1 (AU)
Title: Antimicrobial organosilanes
Inventor: ALLRED GARY
IPC: A61K45/06
Filed: 2020-10-19
Abstract: Organosilicon quaternary ammonium compounds, their formulations, including powdered and solid formulations, and methods of use to treat infections in humans and animals.
Patent AU-2020385059-A1 (AU)
Title: Polypeptides related to HMGB1 useful for promoting tissue regeneration, compositions comprising same, and uses thereof
Inventor: NANCHAHAL JAGDEEP
IPC: A61K35/15
Filed: 2020-11-12
Abstract: This invention provides a polypeptide represented by the following formula: H2N-A-X-B-A-X-B-HOOC wherein A represents consecutive amino acids, the sequence of which (1) includes a sequence identical to the sequence of amino acids 90 – 93 of wildtype HMGB1, (2) has at its amino terminal end, between one and six consecutiveamino acids, for example, 1, 2, 3, 4, 5, or 6 amino acids, the sequence of which isidentical to the sequence of the corresponding one to six amino acids preceding aminoacid 90 in wild type HMGB1, and optionally (3) has a methionine at the aminoterminus;wherein X represents consecutive amino acids, the sequence of which is identical to the sequence of amino acids 94 – 162 of wild type HMGB1; and wherein B represents consecutive amino acids, the sequence of which (1) includes a sequence identical to the sequence of amino acids 163 – 168 of wild type HMGB1 and (2) has at its carboxy terminal end, between one and six consecutive amino acids, for example, 1, 2, 3, 4, 5, or 6 amino acids, the sequence of which is identical to the sequence of the corresponding one to six amino acids following amino acid 168 in wild type HMGB1; and wherein each - represents a peptide bond between each of A and X, X and B, B and A, A and X, and X and B.
Patent AU-2021200353-A1 (AU)
Title: Control assembly coupled to handle of an implement
Inventor: BURNS III JAMES I
IPC: A01D34/68
Filed: 2021-01-20
Abstract: CONTROL ASSEMBLY COUPLED TO HANDLE OF AN IMPLEMENT 
ABSTRACT 
A handle is configured to be coupled to an implement to guide the implement during operation.  
The handle includes a first member configured to be coupled to a main body of the implement, a 
second member movably coupled to the first member between a retracted position and an 
extended position, and a locking mechanism coupled between the first member and the second 
member. The locking mechanism is moveable between a locked position, in which the second 
member is fixed relative to the first member, and an unlocked position, in which the second 
member is movable relative to the first member. The handle also includes a control assembly 
configured to allow operation of the implement in response to the locking mechanism being 
moved into the locked position.
1/12 
LO 
U") 
04 
CD 
co 
CD 
CD 
C*4 
41, -- CD 
CD 
LO 
OD 
C:) C:) 
000 C14 
Lo 
(N 
C:) 
LO 
LO 
LO Q) 
U') 
Et 
U") CD 
CD 
CD 00 
Q0 
C3,> 00 
LO 
co
Patent AU-2021200452-A1 (AU)
Title: Aryl hydrocarbon receptor modulator
Inventor: YANG LUQING
IPC: A61P35/00
Filed: 2021-01-22
Abstract: The invention discloses an aryl hydrocarbon receptor modulators of formula (I), and 
pharmaceutically acceptable salts thereof, 
R R Ra Q 
R 
R 
R N 
R R' (I) 
0 
R' is H, CN, CH2(OH)Ro, CmH2m+1, CnH2n-1, CnH2n-3, -_Wi-\W-W 2 -R3O, 
0 
O
Ro-Wo Ro-WoO 
RO-WO or RO-Wo ;two Ra is independently H, or two Ra together 
form =0 or =N-W3-Ri; A is a C6 to Cio aromatic ring, or a C2 to Cio heteroaromatic ring 
containing 1 to 5 heteroatom selected from N, 0 and S, or 4 to 7 membered non-aromatic 
heterocyclic ring containing 1 to 3 heteroatom selected from N, 0 and S and C=N, which are 
with no substituent or substituted by 1 or 3 R; Q is R, or a C6 to Cio aromatic ring or a C2 to 
Cio heteroaromatic ring containing 1 to 5 heteroatom selected from N, 0 and S, which are 
with no substituent or substituted by 1 or 3 R; R is Rc connected with C or RN connected with 
N. Compounds of this invention of formula (I) can modulate activity of AhR for inhibiting 
growth of cancer cell and inhibiting migration and invasion of tumour cell.
Patent AU-2021202538-A1 (AU)
Title: Adeno-associated virus vector
Inventor: LINDEN RALPH MICHAEL
IPC: C12N15/861
Filed: 2021-04-26
Abstract: C:\Users\aar\AppDaa\Roa ingiManacWork\Recnt\35559801AU A d o- d irs cor\ABSTRACT 35559801(21436901. 1)docx-26/04/2021 
ABSTRACT 
Disclosed herein is a recombinant adeno-associated virus (AAV) vector comprising (a) a 
variant AAV2 capsid protein, wherein the variant AAV2 capsid protein comprises at least 
four amino acid substitutions with respect to a wild type AAV2 capsid protein; wherein the 
at least four amino acid substitutions are present at the following positions in an AAV2 
capsid protein sequence: 457, 492, 499 and 533; and (b) a heterologous nucleic acid 
comprising a nucleotide sequence encoding a gene product.
Patent AU-2021204125-A1 (AU)
Title: Methods and systems for robotic surface coverage
Inventor: EBRAHIMI AFROUZI ALI
IPC: B25J11/00
Filed: 2021-06-19
Abstract: METHODS AND SYSTEMS FOR ROBOTIC SURFACE COVERAGE 
ABSTRACT 
Techniques for minimizing redundancy of surface coverage of a workspace by a robotic device 
are presented, the techniques including: obtaining, with one or more processors of a robot, a map 
of a workspace, the map quantizing the workspace into a plurality of cells, each cell corresponding 
to an area of the workspace; segmenting, with the one or more processors of the robot, the 
workspace into a plurality of zones, each zone having a subset of the plurality of cells; determining, 
with the one or more processors of the robot, a sequence of the zones among a plurality of 
candidate sequences based on an effect of the sequence on a cost of a cost function that is based 
on travel distance of the robot through the sequence; and causing, with the one or more processors 
of the robot, the robot to traverse the zones in the determined sequence.  
50
FIG.l1A 
10 2 100 
104 ____ 
105 
103 ly 
FIG.l1B 
106 
00 
1 89'89 9' 90
Patent AU-2021206184-A1 (AU)
Title: Maritime vehicle systems and methods
Inventor: LEBO WILLIAM TIMOTHY
IPC: B63G8/00
Filed: 2021-01-05
Abstract: Implementations described and claimed herein provide an underwater vehicle includes a vehicle body having a frame enclosed by a fairing. The vehicle body extends between a proximal end and a distal end and defining an interior. A nose is disposed at the proximal end of the vehicle body. The nose has a tow system configured to move between a tow position and a stow position. A propulsion system is disposed at the distal end of the vehicle body. The propulsion system includes a plurality of control fins and a thruster. A power distribution system is housed in the interior of the vehicle body. The power distribution system includes a first power system housed in a first pressure vessel and a second power system housed in a second pressure vessel. The first pressure vessel is isolated from the second pressure vessel.
Patent AU-2021212168-A1 (AU)
Title: Systems, apparatuses, and methods for securing screen assemblies
Inventor: NEWMAN CHRISTIAN
IPC: B07B1/46
Filed: 2021-08-09
Abstract: A gait modulation system, comprising a gait sensor module configured to detect a plurality of gait 
events, the plurality of gait events including a heel-on event and a heel-off event, the gait sensor 
module configured to detect a first gait event from the plurality of gait events and produce a first 
signal when the first gait event is detected, the gait sensor module configured to calculate a time 
period based on a time between the heel-on event and the heel-off event within which a second gait 
event from the plurality of gait events subsequent to the first gait event should be detected by the gait 
sensor module, the gait sensor module configured to produce a second signal when the second gait 
event is not detected by the gait sensor module within the time period; and a functional electrical 
stimulation system configured to receive at least one of the first signal and the second signal.
WO 2007/125534 PCT/1L,2007/000531 
00 
II
Patent AU-2021225283-A1 (AU)
Title: Method for preventing, treating or delaying heart failure by using neuregulin, and composition
Inventor: ZHOU MINGDONG
IPC: G01N33/53
Filed: 2021-02-19
Abstract: The present invention provides an application of neuregulin protein in the preparation of drugs for preventing, treating or delaying human heart failure, and a use method of the drugs for preventing, treating or delaying human heart failure. The method comprises: testing a patient first before treatment, the testing comprises detecting the plasma level of NT-proBNP or BNP; and then providing appropriate treatment on the basis of the test result. When the test result is within an optimal treatment range, the patient is suitable for the treatment of heart failure by administering an effective dose of neuregulin.
Patent AU-2021237602-A1 (AU)
Title: Magnetic flux bias for pulse shaping of microwave signals
Inventor: ABDO BALEEGH
IPC: H03D7/00
Filed: 2021-03-04
Abstract: A technique relates to a pulse shaping of microwave signals. In embodiments a nondegenerate mixing device receives signals and a time-varying magnetic flux via input ports. The nondegenerate mixing device uses the signals and the time-varying magnetic flux to generate an output signal on an output port, the output signal having a waveform profile set by the time-varying magnetic flux.
Patent AU-2021240819-A1 (AU)
Title: Quercetin enhancement formulation
Inventor: SMITH MARGARET
IPC: A61K33/30
Filed: 2021-03-25
Abstract: Compositions comprising 6,7-dihydroxybergamottin (6,7-DHB) and quercetin wherein the bioavailability of quercetin is enhanced as a result of the inhibition of cytochrome P450 enzymes from 6,7-DHB. The compositions are also used in methods of treating cancer, inflammation, cardiovascular disease, hypertension, polycystic ovary syndrome, a neurodegenerative disease, an infection or for enhancing cellular zinc uptake.
Patent AU-2021248179-A1 (AU)
Title: Medical syringe barrel and method for producing same
Inventor: YOSHIDA TAKAYUKI
IPC: B29C45/00
Filed: 2021-03-31
Abstract: [Problem] To provide: a medical syringe barrel that is a molded article made by injection molding of a synthetic resin, that can be completed without requiring post-processing such as polishing, and that is able to be accurately filled with a predetermined amount of an internal-use solution and able to administer the same; and a method for producing same. [Solution] A medical syringe barrel comprising: a cylindrical barrel section for accommodating an internal-use solution in the interior thereof; an injection nozzle section formed at one end of the barrel section; and a flange section projecting radially outward and provided to an opening section of the other end of the barrel section. The flange section surface has a recess, and a weld line that is potentially formed by injection molding is not formed in an internal-use solution filling section.
Patent AU-2021279371-A1 (AU)
Title: Method of making a water-soluble polymer, water-soluble polymer so produced, and melt-processable water-soluble polymer composition
Inventor: MORRIS PETER
IPC: C08K5/00
Filed: 2021-05-11
Abstract: A method of creating a processable water soluble polymer, the method comprising the steps of: extruding a water soluble polymer composition from an extruder barrel without use of a die, wherein the extruder barrel is not vented other than via its extruder outlet, to produce an irregularly shaped polymer extrudate; directing the irregularly shaped polymer extrudate onto a chilled conveyor to cool the irregularly shaped polymer extrudate to below 60°C; and granulating the irregularly shaped polymer extrudate to form a granulate.
Patent AU-2021287380-A1 (AU)
Title: Selective CDK4/6 inhibitor cancer therapeutics
Inventor: LISANTI MICHAEL P
IPC: C07D487/20
Filed: 2021-06-10
Abstract: This disclosure describes embodiments of selective and potent CDK 4/6 inhibitors that show advantageous inhibition of cancer growth, even at low concentrations. As described herein, compounds of the present approach comprise substituted pyridinylpiperazine-pyrrolopyrimidine compounds having a fatty acid moiety. The compounds described herein may be used as pharmaceutical compounds for anti-cancer therapies, and are useful for the treatment, prevention and/or amelioration of cancer. Formula (a)
Patent AU-2021290282-A1 (AU)
Title: Load transport system for transporting a load in a working space
Inventor: KLAPPER GEORG
IPC: B66C13/04
Filed: 2021-12-22
Abstract: Load transport system (1) which has a load carrier (4) and at least one load 
receiving device (5) which for receiving the load (2) is fastened to the load carrier (4), 
and at least three positioning cables (6) and at least three suspension devices (7), 
wherein each suspension device (7) has at least one positioning cable winch (8) for 
winding and unwinding one of the positioning cables (6), and the load carrier (4) by 
means of the positioning cables (6) is suspended from the suspension devices (7), 
wherein the load carrier (4) and the load receiving device (5) fastened thereto are able 
to be relocated by activating the positioning cable winches (8), and the load carrier (4) 
has at least one multi-cable suspension (20) by means of which at least two of the 
positioning cables (6) are in each case connected to the load carrier (4) by way of one 
cable connector (21), wherein each of the cable connectors (21) is mounted on the 
multi-cable suspension (20) so as to be pivotable about at least two pivot axes (22, 23, 
24, 25) aligned so as to be mutually orthogonal, and all pivot axes (22, 23, 24, 25) of 
the cable connectors (21) intersect in a common intersection point (39) of this multi
cable suspension (20). (Fig. 9)
4/14 
Fig.9 10 36 
4 21 
176 
6 60 
237 
421 
3 6 38--
36 
14 5 
Fig. 10 
6 
4 21 
26 23 2 211 
20 17 
25 
20 '6 
21
Patent AU-2021299515-A1 (AU)
Title: 2-(indazol-5-yl)-6-(piperidin-4-yl)-1,7-naphthyridine derivatives and related compounds as modulators for splicing nucleic acids and for the treatment of proliferative diseases
Inventor: REYNOLDS DOMINIC
IPC: A61P35/02
Filed: 2021-07-02
Abstract: The present disclosure features compounds of formula (l-a) and of formula (II) and pharmaceutical compositions thereof. The present disclosure further discloses the compounds of formula (I- a) and (II) and their compositions for use in methods of modulating nucleic acid splicing, e.g., splicing of a pre-mRNA, as well as said compounds for use in methods of treating e.g.: • proliferative diseases, such as e.g. cancer, benign neoplasms or angiogenesis, • neurological diseases or disorders, such as e.g. Huntington's disease, • autoimmune diseases or disorders, immunodeficiency diseases or disorders, lysosomal storage disease or disorder, cardiovascular diseases or disorders, metabolic diseases or disorders, respiratory diseases or disorders, renal diseases or disorders, or infectious diseases. Exemplary compounds are e.g. 2-(indazol-5-yl)-6-(piperidin-4-yl)-l,7- naphthyridine derivatives and similar compounds.
Patent AU-2021307397-A1 (AU)
Title: Branched amino acid surfactants for use in healthcare products
Inventor: ASIRVATHAM EDWARD
IPC: A61K9/107
Filed: 2021-07-12
Abstract: Healthcare formulations, including, inventive surfactants, Active ingredient formulated as solids, liquids, or emulsions. The present disclosure provides formulations of healthcare products, such as: prescription drugs, over the counter drugs; minerals, herbal, and/or vitamin supplements; drugs administered in hospitals, clinics, physician's office, and places of palliative care; vaccines, tissue, organ, and cell transplants and/or grafts and/or infusions; and wound care formulations including topical ointments, lotions, cleaners, wipes, bandages, and dressings. The Active may be included in the formulations as a solute, a solvent, a particle, or an oil immiscible component of the formulation. The Active may be included in tablets, capsules, tinctures, liquids, or emulsions. Inventive healthcare formulations include formulations suitable for administration orally, topically, and/or by injection.
Patent AU-2021322289-A1 (AU)
Title: Devices to support and position an intraocular lens within the eye and methods of use
Inventor: CLARKE MATTHEW
IPC: A61F2/14
Filed: 2021-08-06
Abstract: An implantable device for supporting an artificial intraocular lens in an eye having an anterior segment of a capsular bag, an iris, and a sclera. The device includes a posterior platform having an anterior-facing surface and an inner wall defining, at least in part, a central aperture. When the device is implanted in the eye, light passes through the intraocular lens and the central aperture of the posterior platform towards the retina. The device includes at least one awning positioned over the anterior-facing surface of the posterior platform forming at least one recess anterior to the posterior platform. The device is configured to be deployed in the eye posterior of the iris so that no portion of the device rests in contact with the sclera after implantation. Related tools, systems, and methods are provided.
Patent AU-2021323853-A1 (AU)
Title: Milbemycin oxime and praziquantel flavor tablets and preparation method therefor
Inventor: XIE DENGLONG
IPC: A61K47/46
Filed: 2021-08-12
Abstract: The present invention relates to a milbemycin oxime and praziquantel flavor tablet and a preparation method therefor. The milbemycin oxime and praziquantel flavor tablet of the present invention consists of a tablet core and a drug-free coating layer coated on the surface of the tablet core. One or more coating layers can be present. The coating layer contains at least one phagostimulant or corrigent. The tablet core consists of a pellet, a glidant, and a lubricant. The preparation process of the milbemycin oxime and praziquantel flavor tablet of the present invention comprises drug-containing powder→micropellet→tablet core→coating layer→flavor tablet. The preparation process is simple, and can uniformly mix a main drug and assistants together, so that the assistants can better function, the stability of the drug is improved, the taste of the drug is improved, and the flavor tablet is suitable for industrial production, and has wide application prospects.
Patent AU-2021325330-A1 (AU)
Title: Test strip fixation device for optical measurements of an analyte
Inventor: BERG MAX
IPC: G01N21/25
Filed: 2021-08-09
Abstract: The present invention relates to a test strip fixation device - being configured to be used in a method for determining a concentration of an analyte in a bodily fluid by using a mobile device having a camera, said method comprising capturing by the camera at least one image containing at least a part of an optical test strip and at least a part of said test strip fixation device, the optical test strip having a sample of the bodily fluid applied onto a reagent test region of the optical test strip, wherein the image comprises at least a part of the reagent test region having the sample of the bodily fluid applied thereto, and wherein the image comprises at least a part of a top surface of the test strip fixation device; said test strip fixation device comprising a) an essentially planar shape; b) a cut-out portion; c) a top surface comprising a plurality of color reference fields having known reference color values, including grey reference fields locally arranged around the cut-out portion and around at least some of the non-grey color reference fields; and comprising position detection code elements; d) a bottom surface comprising a fixation element for detachable connection of the optical test strip relative to said test strip fixation device, such that the reagent test region can be aligned with the cut-out portion.
Patent AU-2021333331-A1 (AU)
Title: Ship
Inventor: TANAKA TAICHI
IPC: F17C13/08
Filed: 2021-08-24
Abstract: This ship comprises a hull, a tank, a lower support section, and an elastic support section. The tank is installed on the hull and is filled with liquefied gas. In the cross-sectional shape of the tank orthogonal to the fore-and-aft direction, the vertical direction is the longitudinal direction, and the lower support section supports the tank from below on the hull. The elastic support section elastically supports the tank higher than the lower support section on the hull.
Patent AU-2021349385-A1 (AU)
Title: Humanized anti-liv1 antibodies for the treatment of cancer
Inventor: ONSUM MATT
IPC: A61K47/68
Filed: 2021-09-27
Abstract: Methods for using anti-LIV1 antibodies and antibody-drug conjugates, including anti-LIV1 antibody-drug conjugates, to inhibit proliferation of a cell, as well as for the treatment of cancers, such as, e.g., prostate cancer and melanoma, are provided.